1. Home
  2. HIMX vs NNNN Comparison

HIMX vs NNNN Comparison

Compare HIMX & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Himax Technologies Inc.

HIMX

Himax Technologies Inc.

HOLD

Current Price

$7.38

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$22.71

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIMX
NNNN
Founded
2001
2021
Country
Taiwan
Germany
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
HIMX
NNNN
Price
$7.38
$22.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
39.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.94
N/A
Revenue Next Year
$7.79
N/A
P/E Ratio
$14.99
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$5.66
$5.91
52 Week High
$9.85
$55.65

Technical Indicators

Market Signals
Indicator
HIMX
NNNN
Relative Strength Index (RSI) 42.61 44.41
Support Level $7.14 $22.08
Resistance Level $8.85 $31.44
Average True Range (ATR) 0.29 2.46
MACD 0.02 -0.09
Stochastic Oscillator 45.51 16.81

Price Performance

Historical Comparison
HIMX
NNNN

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: